Colorectal cancer (CRC) is still a leading cause of cancer death worldwide. Less than half of
cases are diagnosed when the cancer is locally advanced. CRC is a heterogenous disease …

Tissue-based biopsy is the present main tool to explore the molecular landscape of cancer,
but it also has many limits to be frequently executed, being too invasive with the risk of side …

The incidence of sporadic young-onset colorectal cancer (yCRC) is increasing. A significant
knowledge gap exists in the gut microbiota and its diagnostic value for yCRC patients …

Colorectal cancer (CRC) is one of the most common malignancies that is usually detected
late in the clinic. The currently available diagnostic tools for CRC are either invasive or …

Trillions of microbes inhabit the human gut and build extremely complex communities. Gut
microbes contribute to host metabolisms for better or worse and are widely studied and …

Background & Aims Fecal tests currently used for colorectal cancer (CRC) screening show
limited accuracy in detecting early tumors or precancerous lesions. In this respect, we …

Colorectal carcinoma (CRC) is the third most common cancer in terms of diagnosis and the
second in terms of mortality. Recent studies have shown that various proteins, such as …

Colorectal cancer (CRC) is one of the most common malignancies and is a major cause of
cancer-related deaths worldwide. Thus, there is a clinical need to improve early detection of …

Simple Summary Early diagnosis is critically important to achieve life-saving therapy for
colorectal cancer (CRC). Since colonoscopy is not suitable as a screening method for CRC …

Over the past decade, short non-coding microRNAs (miRNAs), including circulating and
fecal miRNAs have emerged as important modulators of various cellular processes by …